...
Read More
Merck and Moderna's Cancer Vaccine Worked—Who Gets Paid?
The personalized melanoma vaccine cut recurrence risk by 42%, but its commercial payoff looks far bigger for Moderna than for Merck. He...
Read More
Monetary Medicine My...
The Fed quietly explained the machinery keeping Treasury funding alive, including a tool it has stopped using. ͏ ͏ ͏ ͏ ...
Read More
Subscribe to:
Posts (Atom)